Jazz Pharmaceuticals stock pops as President Trump signals renewed urgency to reclassify cannabis as Schedule III drug.

President Trump's executive order is giving psychedelic stocks a boost. These companies are leaders in the industry.

Shares of several pharmaceutical companies were up after President Trump signed an executive order aimed at accelerating research, development access to psychedelic medicines for the treatment of ...

Granted, revenue has still been higher over the past few years than it was before COVID-19, but the stock price is also down ...

Arrowhead Pharmaceuticals (ARWR) gains 3.9% after Morgan Stanley upgrade. Stock up 481% in 12 months with analysts ...

Organon (OGN) stock jumped 41% after Sun Pharmaceutical submitted a $12B all-cash acquisition offer, backed by JPMorgan and ...

Discover the Sun Pharma Stock Liveblog, your go-to destination for real-time updates and comprehensive analysis of a ...

Pharmaceutical companies thrive due to aging populations and rising healthcare costs. Analyzing key financial ratios helps investors evaluate pharma firms. Pharma companies offer a broad selection of ...

The global pharmaceutical market is valued at $1.7 trillion, offering lucrative investment prospects. Choosing the right pharmaceutical stocks involves evaluating consistent revenue growth and robust ...

Biotech stocks surged in 2025, driven by FDA approvals, M&A activity, and rising longevity investment. Explore key trends, ...